oxycodone has been researched along with noroxycodone in 48 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (8.33) | 18.2507 |
| 2000's | 17 (35.42) | 29.6817 |
| 2010's | 23 (47.92) | 24.3611 |
| 2020's | 4 (8.33) | 2.80 |
| Authors | Studies |
|---|---|
| Eddington, ND; Hassan, HE; Lee, IJ; Mason, CW; Myers, AL; Sinz, MW; Wang, D; Wang, H | 1 |
| Brockmöller, J; Friesacher, HR; Meyer, MJ; Neumann, VE; Tzvetkov, MV; Zdrazil, B | 1 |
| Kalso, E; Olkkola, KT; Pöyhiä, R; Seppälä, T | 1 |
| Leow, KP; Smith, MT | 1 |
| Benziger, DP; Burke, BE; Fitzmartin, RD; Goldenheim, PD; Kaiko, RF; Reder, RF | 1 |
| Kirvela, M; Lindgren, L; Olkkola, KT; Seppala, T | 1 |
| Heiskanen, TE; Kalso, EA; Ruismäki, PM; Seppälä, TA | 1 |
| Davis, M; Reder, RF; Stambaugh, H; Stambaugh, JE; Stambaugh, MD | 1 |
| Fowler, D; Levine, B; Moore, KA; Ramcharitar, V | 1 |
| Howald, W; Lalovic, B; Phillips, B; Risler, LL; Shen, DD | 1 |
| Boström, E; Hammarlund-Udenaes, M; Jansson, B; Simonsson, US | 1 |
| Edwards, SR; Smith, MT | 2 |
| Baldacci, A; Thormann, W | 1 |
| Bachmakov, I; Brune, K; Cheremina, O; Fromm, MF; Hinz, B; Neubert, A | 1 |
| Cooper, RM; Lee, MA; Leng, ME | 1 |
| Edwards, SR; Huang, L; Smith, MT | 1 |
| Kokki, H; Lasalmi, M; Lehtola, S; Ojanperä, I; Ranta, VP; Rasanen, I; Vanamo, K | 1 |
| Kalso, EA; Kontinen, VK; Korpi, ER; Lemberg, KK; Siiskonen, AO; Viljakka, KM; Yli-Kauhaluoma, JT | 1 |
| Chan, S; Edwards, SR; Smith, MT; Wyse, BD | 1 |
| Chida, M; Hosokawa, T; Kamoto, T; Miura, T; Narabayashi, M; Nishimura, K; Onozawa, Y; Saijo, Y; Shimoyama, N; Takenoshita, S; Tani, K; Tsushima, T | 1 |
| Neuvonen, M; Neuvonen, PJ | 1 |
| Al-Asmari, AI; Anderson, RA; Cooper, GA | 1 |
| Black, DL; Caplan, YH; Cawthon, B; Cone, EJ; Heltsley, R; Moser, F; Robert, T; Zichterman, A | 1 |
| Grönlund, J; Hagelberg, NM; Laine, K; Neuvonen, M; Neuvonen, PJ; Olkkola, KT; Saari, TI | 1 |
| Bourgogne, E; Hopfgartner, G; Varesio, E; Wagner, M | 1 |
| Drewe, J; Hammann, F; Krähenbühl, S; Kummer, O; Moser, C; Schaller, O | 1 |
| Andreassen, TN; Bjordal, K; Dale, O; Davies, A; Kaasa, S; Klepstad, P; Lundström, S | 1 |
| Aantaa, R; Kuusniemi, K; Liukas, A; Neuvonen, M; Neuvonen, PJ; Olkkola, KT; Virolainen, P | 1 |
| Kagawa, Y; Kawakami, J; Naito, T; Ohnishi, K; Takashina, Y; Tashiro, M; Yamamoto, K | 1 |
| Anderson, H; Charles, B; Hardy, J; Norris, R; O'Shea, A | 1 |
| Book, M; Lehmann, LE; Musshoff, F; Stamer, UM; Stuber, F; Zhang, L | 1 |
| Black, DL; Cone, EJ; Flegel, RR; Heltsley, R; Lodico, CP; Mitchell, JM | 1 |
| Ishida, T; Kawakami, J; Naito, T; Ohnishi, K; Tashiro, M | 1 |
| Atayee, RS; Best, BM; Elder, NM; Ma, JD | 1 |
| Dong, RH; Gao, HZ; Hao, GT; Li, YY; Liang, YG; Liu, ZY; Qu, HY; Wang, XF; Zhang, LJ; Zhou, HY | 1 |
| Chayahara, N; Fujiwara, Y; Imamura, Y; Kiyota, N; Minami, H; Mukohara, T; Shimada, T; Toyoda, M | 1 |
| Gaudette, F; Michaud, V; Sirhan-Daneau, A; St-Onge, M; Turgeon, J | 1 |
| Cavallari, G; Croci Chiocchini, AL; Di Nino, G; Donati, G; Gori, A; La Manna, G; Mandrioli, R; Melotti, RM; Mercolini, L; Protti, M; Samolsky Dekel, BG; Vasarri, A | 1 |
| Hautajärvi, H; Heikkinen, M; Hokkanen, J; Kokki, H; Kokki, M; Pitkänen, H; Ranta, VP; Sankilampi, U; Välitalo, P | 1 |
| Brauneis, S; Busardò, FP; Forneris, A; Kyriakou, C; Marinelli, E; Pacifici, R; Pantano, F; Pichini, S | 1 |
| Catapano, MC; Gerra, G; Mandrioli, R; Mercolini, L; Protti, M; Rudge, J; Samolsky Dekel, BG; Somaini, L | 1 |
| Amico, P; Dickenmann, M; Duthaler, U; Hammann, F; Haschke, M; Jehle, AW; Kalbermatter, S; Krähenbühl, S; Lenherr, C; Leuppi-Taegtmeyer, A; Liechti, ME; Meyer Zu Schwabedissen, HE; Schmid, Y | 1 |
| Batchelor, RH; Bornhop, DJ; Drabek, R; Gandhi, I; Jackson, GW; Kammer, MN; Kussrow, A | 1 |
| Cashman, JR; de Kater, A; Gohdes, M; Schoenhard, G | 1 |
| Cantillo, D; Chen, Y; Glotz, G; Kappe, CO | 1 |
| Gréen, H; Jakobsson, G; Kronstrand, R; Larsson, R; Pellè, L | 1 |
| Al-Qurain, AA; Mackenzie, L; Roberts, MS; Wiese, MD; Williams, DB | 1 |
14 trial(s) available for oxycodone and noroxycodone
| Article | Year |
|---|---|
The pharmacokinetics and metabolism of oxycodone after intramuscular and oral administration to healthy subjects.
Topics: Administration, Oral; Adult; Amitriptyline; Chromatography, Gas; Double-Blind Method; Female; Humans; Injections, Intramuscular; Male; Morphinans; Oxycodone; Oxymorphone; Placebos; Reference Values | 1992 |
The pharmacokinetics of oxycodone in uremic patients undergoing renal transplantation.
Topics: Adult; Analgesics, Opioid; Biotransformation; Female; Half-Life; Humans; Injections, Intravenous; Kidney Transplantation; Male; Morphinans; Oxycodone; Oxymorphone; Uremia | 1996 |
Morphine or oxycodone in cancer pain?
Topics: Administration, Oral; Adult; Aged; Analgesics, Opioid; Cross-Over Studies; Cytochrome P-450 CYP2D6; Debrisoquin; Delayed-Action Preparations; Double-Blind Method; Female; Humans; Male; Middle Aged; Morphinans; Morphine; Morphine Derivatives; Neoplasms; Oxycodone; Pain; Pain Measurement; Phenotype | 2000 |
Double-blind, randomized comparison of the analgesic and pharmacokinetic profiles of controlled- and immediate-release oral oxycodone in cancer pain patients.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Analgesics, Opioid; Biological Availability; Chronic Disease; Cross-Over Studies; Delayed-Action Preparations; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Morphinans; Neoplasms; Oxycodone; Oxymorphone; Pain; Pain Measurement; Therapeutic Equivalency; Vomiting | 2001 |
Comparison of oxycodone pharmacokinetics after buccal and sublingual administration in children.
Topics: Administration, Buccal; Administration, Sublingual; Analgesics, Opioid; Area Under Curve; Child; Child, Preschool; Female; Gas Chromatography-Mass Spectrometry; Half-Life; Humans; Indicators and Reagents; Infant; Male; Morphinans; Oxycodone; Oxymorphone | 2006 |
Opioid rotation from oral morphine to oral oxycodone in cancer patients with intolerable adverse effects: an open-label trial.
Topics: Administration, Oral; Aged; Analgesics, Opioid; Constipation; Drug Administration Schedule; Female; Humans; Linear Models; Male; Middle Aged; Morphinans; Morphine; Morphine Derivatives; Nausea; Neoplasms; Oxycodone; Pain; Prospective Studies; Renal Insufficiency, Chronic; Sleep Stages; Treatment Outcome; Vomiting | 2008 |
Effect of the inhibition of CYP3A4 or CYP2D6 on the pharmacokinetics and pharmacodynamics of oxycodone.
Topics: Adult; Analgesics, Opioid; Cross-Over Studies; Cytochrome P-450 CYP2D6 Inhibitors; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Double-Blind Method; Drug Interactions; Genotype; Humans; Ketoconazole; Miosis; Morphinans; Oxycodone; Oxymorphone; Pain Measurement; Paroxetine; Placebos; Young Adult | 2011 |
Influences on the pharmacokinetics of oxycodone: a multicentre cross-sectional study in 439 adult cancer patients.
Topics: Analgesics, Opioid; Cross-Sectional Studies; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Dose-Response Relationship, Drug; Female; Humans; Linear Models; Male; Middle Aged; Morphinans; Neoplasms; Oxycodone; Oxymorphone; Pain; Sex Factors | 2011 |
Elimination of intravenous oxycodone in the elderly: a pharmacokinetic study in postoperative orthopaedic patients of different age groups.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Analgesics, Opioid; Area Under Curve; Chromatography, Liquid; Creatinine; Cytochrome P-450 CYP2D6; Female; Genotype; Glomerular Filtration Rate; Humans; Injections, Intravenous; Male; Middle Aged; Morphinans; Orthopedic Procedures; Oxycodone; Oxymorphone; Pain, Postoperative; Tandem Mass Spectrometry; Tissue Distribution; Young Adult | 2011 |
CYP3A5*3 affects plasma disposition of noroxycodone and dose escalation in cancer patients receiving oxycodone.
Topics: Aged; Asian People; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Delayed-Action Preparations; Female; Humans; Male; Middle Aged; Morphinans; Neoplasms; Oxycodone; Oxymorphone; Polymorphism, Genetic; Receptors, Opioid, mu | 2011 |
Cancer cachexia raises the plasma concentration of oxymorphone through the reduction of CYP3A but not CYP2D6 in oxycodone-treated patients.
Topics: Aged; Analgesics, Opioid; Cachexia; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Female; Humans; Male; Middle Aged; Morphinans; Neoplasms; Oxycodone; Oxymorphone; Pain | 2013 |
Effects of aprepitant on the pharmacokinetics of controlled-release oral oxycodone in cancer patients.
Topics: Adult; Aged; Analgesics, Opioid; Aprepitant; Area Under Curve; Delayed-Action Preparations; Female; Humans; Male; Middle Aged; Morphinans; Morpholines; Neoplasms; Oxycodone; Oxymorphone; Pain | 2014 |
Maturation of oxycodone pharmacokinetics in neonates and infants: Oxycodone and its metabolites in plasma and urine.
Topics: Age Factors; Analgesics, Opioid; Child, Preschool; Female; Half-Life; Humans; Infant; Infant, Extremely Premature; Infant, Newborn; Infant, Premature; Male; Morphinans; Oxycodone; Prospective Studies; Time Factors | 2017 |
Pharmacokinetics of oxycodone/naloxone and its metabolites in patients with end-stage renal disease during and between haemodialysis sessions.
Topics: Adult; Aged; Analgesics, Opioid; Cross-Over Studies; Female; Humans; Kidney Failure, Chronic; Kidney Function Tests; Male; Middle Aged; Morphinans; Naloxone; Narcotic Antagonists; Oxycodone; Oxymorphone; Prognosis; Renal Dialysis; Tissue Distribution | 2019 |
34 other study(ies) available for oxycodone and noroxycodone
| Article | Year |
|---|---|
Induction of xenobiotic receptors, transporters, and drug metabolizing enzymes by oxycodone.
Topics: Animals; Cell Line, Tumor; Gene Expression; Humans; Liver; Male; Oxycodone; Polymerase Chain Reaction; Rats; Rats, Sprague-Dawley; Real-Time Polymerase Chain Reaction; Receptors, Drug; Transcriptional Activation; Xenobiotics | 2013 |
Opioids as Substrates and Inhibitors of the Genetically Highly Variable Organic Cation Transporter OCT1.
Topics: Analgesics, Opioid; HEK293 Cells; Humans; Inhibitory Concentration 50; Models, Molecular; Organic Cation Transporter 1; Permeability; Protein Conformation | 2019 |
The antinociceptive potencies of oxycodone, noroxycodone and morphine after intracerebroventricular administration to rats.
Topics: Animals; Dose-Response Relationship, Drug; Injections, Intraventricular; Male; Morphinans; Morphine; Naloxone; Nociceptors; Oxycodone; Rats; Rats, Sprague-Dawley | 1994 |
Pharmacokinetic-pharmacodynamic relationships of controlled-release oxycodone.
Topics: Administration, Oral; Adult; Aged; Analgesics, Opioid; Delayed-Action Preparations; Female; Humans; Male; Morphinans; Oxycodone; Oxymorphone; Reference Values | 1996 |
Tentative identification of novel oxycodone metabolites in human urine.
Topics: Analgesics, Opioid; Chromatography, Gas; Forensic Medicine; Humans; Morphinans; Oxycodone; Substance Abuse Detection | 2003 |
Quantitative contribution of CYP2D6 and CYP3A to oxycodone metabolism in human liver and intestinal microsomes.
Topics: Aryl Hydrocarbon Hydroxylases; Biotransformation; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; DNA, Complementary; Humans; Intestinal Mucosa; Intestines; Ketoconazole; Kinetics; Metabolic Clearance Rate; Methylation; Microsomes; Microsomes, Liver; Molecular Structure; Morphinans; Oxidoreductases, N-Demethylating; Oxycodone; Oxymorphone; Protein Binding; Quinidine | 2004 |
The use of liquid chromatography/mass spectrometry for quantitative analysis of oxycodone, oxymorphone and noroxycodone in Ringer solution, rat plasma and rat brain tissue.
Topics: Analgesics, Opioid; Animals; Brain Chemistry; Chromatography, High Pressure Liquid; Injections, Intravenous; Isotonic Solutions; Morphinans; Oxycodone; Oxymorphone; Rats; Reproducibility of Results; Ringer's Solution; Spectrometry, Mass, Electrospray Ionization | 2004 |
Simultaneous determination of morphine, oxycodone, morphine-3-glucuronide, and noroxycodone concentrations in rat serum by high performance liquid chromatography-electrospray ionization-tandem mass spectrometry.
Topics: Animals; Chromatography, High Pressure Liquid; Morphinans; Morphine; Morphine Derivatives; Oxycodone; Rats; Reproducibility of Results; Sensitivity and Specificity; Spectrometry, Mass, Electrospray Ionization | 2005 |
Analysis of oxycodol and noroxycodol stereoisomers in biological samples by capillary electrophoresis.
Topics: Electrophoresis, Capillary; Humans; Liver; Morphinans; Oxycodone; Stereoisomerism | 2005 |
Simultaneous determination of oxycodone and its major metabolite, noroxycodone, in human plasma by high-performance liquid chromatography.
Topics: Adult; Chromatography, High Pressure Liquid; Humans; Male; Morphinans; Oxycodone; Sensitivity and Specificity; Ultraviolet Rays | 2005 |
Measurements of plasma oxycodone, noroxycodone and oxymorphone levels in a patient with bilateral nephrectomy who is undergoing haemodialysis.
Topics: Analgesics, Opioid; Female; Humans; Kidney Failure, Chronic; Middle Aged; Morphinans; Nephrectomy; Oxycodone; Oxymorphone; Renal Dialysis | 2005 |
Comparison of the pharmacokinetics of oxycodone and noroxycodone in male dark agouti and Sprague--Dawley rats: influence of streptozotocin-induced diabetes.
Topics: Alcohol Oxidoreductases; Analgesics, Opioid; Animals; Aryl Hydrocarbon Hydroxylases; Chromatography, High Pressure Liquid; Cytochrome P450 Family 2; Diabetes Mellitus, Experimental; Male; Morphinans; Oxycodone; Rats; Rats, Sprague-Dawley; Species Specificity; Spectrometry, Mass, Electrospray Ionization; Streptozocin | 2005 |
Antinociception by spinal and systemic oxycodone: why does the route make a difference? In vitro and in vivo studies in rats.
Topics: Algorithms; Analgesics, Opioid; Animals; Area Under Curve; Autoradiography; Dose-Response Relationship, Drug; GTP-Binding Proteins; Guanosine 5'-O-(3-Thiotriphosphate); Injections, Intravenous; Injections, Spinal; Male; Morphinans; Morphine; Motor Activity; Oxycodone; Oxymorphone; Pain Measurement; Rats; Rats, Sprague-Dawley; Receptors, Opioid, kappa; Receptors, Opioid, mu; Signal Transduction | 2006 |
Low-level quantitation of oxycodone and its oxidative metabolites, noroxycodone, and oxymorphone, in rat plasma by high-performance liquid chromatography-electrospray ionization-tandem mass spectrometry.
Topics: Analgesics, Opioid; Animals; Calibration; Chromatography, High Pressure Liquid; Injections, Intravenous; Male; Molecular Structure; Morphinans; Oxycodone; Oxymorphone; Rats; Rats, Sprague-Dawley; Reproducibility of Results; Spectrometry, Mass, Electrospray Ionization; Tandem Mass Spectrometry; Time Factors | 2007 |
Sex differences in the pharmacokinetics, oxidative metabolism and oral bioavailability of oxycodone in the Sprague-Dawley rat.
Topics: Administration, Oral; Analgesics, Opioid; Animals; Biological Availability; Female; Male; Morphinans; Oxidation-Reduction; Oxycodone; Oxymorphone; Rats; Rats, Sprague-Dawley; Sex Characteristics | 2008 |
Determination of oxycodone, noroxycodone, oxymorphone, and noroxymorphone in human plasma by liquid chromatography-electrospray-tandem mass spectrometry.
Topics: Analgesics, Opioid; Chromatography, High Pressure Liquid; Humans; Indicators and Reagents; Morphinans; Oxycodone; Oxymorphone; Reference Standards; Reproducibility of Results; Spectrometry, Mass, Electrospray Ionization; Spectrophotometry, Ultraviolet | 2008 |
Oxycodone-related fatalities in the west of Scotland.
Topics: Adult; Aged; Cause of Death; Chromatography, High Pressure Liquid; Female; Humans; Male; Middle Aged; Morphinans; Mortality; Narcotics; Oxycodone; Reproducibility of Results; Scotland; Spectrometry, Mass, Electrospray Ionization; Substance Abuse Detection; Substance-Related Disorders; Tandem Mass Spectrometry | 2009 |
Urine testing for norcodeine, norhydrocodone, and noroxycodone facilitates interpretation and reduces false negatives.
Topics: Analgesics, Opioid; Chromatography, Liquid; Codeine; False Negative Reactions; Forensic Toxicology; Humans; Hydrocodone; Medication Adherence; Morphinans; Oxycodone; Oxymorphone; Pain; Tandem Mass Spectrometry | 2010 |
Effects of itraconazole on the pharmacokinetics and pharmacodynamics of intravenously and orally administered oxycodone.
Topics: Analgesics, Opioid; Area Under Curve; Cross-Over Studies; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Humans; Injections, Intravenous; Itraconazole; Morphinans; Oxidation-Reduction; Oxycodone; Oxymorphone | 2010 |
Quantitation of polar analytes using column-switching: application to oxycodone and three metabolites in human plasma.
Topics: Chromatography, Liquid; Humans; Hydrogen-Ion Concentration; Least-Squares Analysis; Morphinans; Oxycodone; Oxymorphone; Perchlorates; Reproducibility of Results; Sensitivity and Specificity | 2010 |
Is saliva a valid substitute for plasma in pharmacokinetic studies of oxycodone and its metabolites in patients with cancer?
Topics: Adult; Aged; Aged, 80 and over; Analgesics, Opioid; Chromatography, High Pressure Liquid; Delayed-Action Preparations; Dose-Response Relationship, Drug; Drug Monitoring; Female; Humans; Hydrogen-Ion Concentration; Male; Middle Aged; Morphinans; Neoplasms; Oxycodone; Patient Preference; Saliva; Tandem Mass Spectrometry; Time Factors; Young Adult | 2012 |
CYP2D6 genotype dependent oxycodone metabolism in postoperative patients.
Topics: Aged; Analgesics, Opioid; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Female; Genotype; Humans; Male; Middle Aged; Morphinans; Oxycodone; Oxymorphone; Spectrometry, Mass, Electrospray Ionization | 2013 |
Prescription opioids. I. Metabolism and excretion patterns of oxycodone in urine following controlled single dose administration.
Topics: Adult; Analgesics, Opioid; Chromatography, High Pressure Liquid; Employment; Female; Humans; Male; Morphinans; Oxycodone; Oxymorphone; Substance Abuse Detection; Tandem Mass Spectrometry; Time Factors; Workplace; Young Adult | 2013 |
Observations of urinary oxycodone and metabolite distributions in pain patients.
Topics: Adolescent; Adult; Age Factors; Aged; Analgesics, Opioid; Chromatography, Liquid; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP2D6 Inhibitors; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Drug Interactions; Female; Humans; Hydrogen-Ion Concentration; Male; Middle Aged; Morphinans; Oxycodone; Oxymorphone; Pain; Retrospective Studies; Sex Factors; Specimen Handling; Tandem Mass Spectrometry; Young Adult | 2014 |
Pharmacokinetics of oxycodone hydrochloride and three of its metabolites after intravenous administration in Chinese patients with pain.
Topics: Adult; Analgesics, Opioid; Area Under Curve; Female; Humans; Injections, Intravenous; Male; Middle Aged; Morphinans; Oxycodone; Oxymorphone; Pain | 2014 |
Development of a sensitive method for the determination of oxycodone and its major metabolites noroxycodone and oxymorphone in human plasma by liquid chromatography-tandem mass spectrometry.
Topics: Chromatography, Liquid; Humans; Limit of Detection; Morphinans; Oxycodone; Oxymorphone; Reproducibility of Results; Tandem Mass Spectrometry | 2016 |
Dialyzability of Oxycodone and Its Metabolites in Chronic Noncancer Pain Patients with End-Stage Renal Disease.
Topics: Adult; Analgesics, Opioid; Chronic Disease; Chronic Pain; Female; Humans; Kidney Failure, Chronic; Male; Middle Aged; Morphinans; Oxycodone; Oxymorphone; Renal Dialysis | 2017 |
Determination of oxycodone and its major metabolites noroxycodone and oxymorphone by ultra-high-performance liquid chromatography tandem mass spectrometry in plasma and urine: application to real cases.
Topics: Aged; Aged, 80 and over; Chromatography, High Pressure Liquid; Female; Humans; Male; Middle Aged; Morphinans; Oxycodone; Oxymorphone; Tandem Mass Spectrometry | 2017 |
Determination of oxycodone and its major metabolites in haematic and urinary matrices: Comparison of traditional and miniaturised sampling approaches.
Topics: Blood Specimen Collection; Body Fluids; Chromatography, Liquid; Doping in Sports; Dried Blood Spot Testing; Drug Monitoring; Humans; Miniaturization; Morphinans; Oxycodone; Oxymorphone; Plasma; Specimen Handling; Tandem Mass Spectrometry; Urine | 2018 |
Quantification of Opioids in Urine Using an Aptamer-Based Free-Solution Assay.
Topics: Analgesics, Opioid; Aptamers, Nucleotide; Fentanyl; Humans; Hydrocodone; Molecular Structure; Morphinans; Oxycodone | 2019 |
Topics: Analgesics, Opioid; Animals; Cytochrome P-450 Enzyme System; Female; Hemoglobins; Humans; Male; Mixed Function Oxygenases; Morphinans; NADP; Oxides; Oxycodone; Oxymorphone; Rats | 2020 |
Organophotocatalytic N-Demethylation of Oxycodone Using Molecular Oxygen.
Topics: Analgesics; Demethylation; Humans; Morphinans; Oxycodone | 2020 |
Oxycodone findings and CYP2D6 function in postmortem cases.
Topics: Adolescent; Adult; Aged; Analgesics, Opioid; Cytochrome P-450 CYP2D6; DNA Copy Number Variations; Female; Forensic Genetics; Genotype; High-Throughput Nucleotide Sequencing; Humans; Male; Middle Aged; Morphinans; Oxycodone; Pharmacogenomic Testing; Phenotype; Polymorphism, Single Nucleotide; Young Adult | 2021 |
Simultaneous LC-MS/MS quantification of oxycodone, tramadol and fentanyl and their metabolites (noroxycodone, oxymorphone, O- desmethyltramadol, N- desmethyltramadol, and norfentanyl) in human plasma and whole blood collected via venepuncture and volumetr
Topics: Aged; Chromatography, Liquid; Fentanyl; Humans; Morphinans; Oxycodone; Oxymorphone; Reproducibility of Results; Tandem Mass Spectrometry; Tramadol | 2021 |